# BETAMETHASONE DIPROPIONATE

NDC: 45802-505
Generic name: betamethasone dipropionate
Labeler / Manufacturer: Padagis Israel Pharmaceuticals Ltd
Product type: HUMAN PRESCRIPTION DRUG
Marketing category: Abbreviated NDA (generic)
Dosage form: OINTMENT
Routes: TOPICAL
Marketing started: 20220520

FDA application: ANDA215847

## Active ingredients

- BETAMETHASONE DIPROPIONATE: .5 mg/g

## Pharmacological class

—

## External sources

- openFDA: https://api.fda.gov/drug/ndc.json?search=product_ndc:"45802-505"
- FDA NDC Directory: https://www.accessdata.fda.gov/scripts/cder/ndc/dsp_searchresult.cfm?p_ndc=45802-505
- DailyMed: https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=0e56e8bc-b79e-43c6-945e-c333a599bfc8